Trusted Resources
Feb 03, 2022
Genetic counseling gives you information about how genetic conditions might affect you or your family. A genetic counselor will educate you on the process and…
Feb 01, 2022
Rationale & Objective: Test the feasibility of replacing 24-hour urine collection with a single voided urinary protein-creatinine ratio (UPCR) in patients with…
Jan 31, 2022
Although life with amyloidosis can present a variety of challenges, people diagnosed with the condition can experience productive and fulfilling lives by…
Jan 31, 2022
The European Hematology Association (EHA) and International Society of Amyloidosis (ISA) recently agreed to collaborate on the development of guidelines for high-…
Dec 19, 2021
Background: Tafamidis is approved in many countries for the treatment of transthyretin amyloid cardiomyopathy. This study reports data on the long-term efficacy of…
Nov 15, 2021
AL amyloidosis is a systemic amyloidosis and is associated with an underlying plasma cell dyscrasia. High dose intravenous melphalan and autologous stem cell…
Nov 11, 2021
A reliable diagnosis of amyloidosis is usually based on a tissue biopsy. With increasing options for specific treatments of the different amyloid diseases, an exact…
Nov 04, 2021
Amyloidosis is a clinical condition characterized by amyloid fibril deposition into different organ systems. The most common types are light chain (AL) amyloidosis…
Oct 18, 2021
Transthyretin cardiac amyloidosis (ATTR-CA) is increasingly diagnosed owing to the emergence of noninvasive imaging and improved awareness. Clinical penetrance of…
Oct 18, 2021
Immunoglobulin light chain (AL) amyloidosis is an incurable plasma cell disorder characterized by deposition of fibrils of misfolded immunoglobulin free light…